UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study

The Journal of nutrition, health & aging, 2024-08, Vol.28 (8), p.100312, Article 100312

2024

Volltextzugriff (PDF)

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

Scientific reports, 2020-05, Vol.10 (1), p.7741-7741, Article 7741

2020

Volltextzugriff (PDF)

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

Breast cancer research and treatment, 2014-02, Vol.143 (3), p.507-515

2014

Volltextzugriff (PDF)

Non surgical predicting factors for patient satisfaction after third molar surgery

Medicina oral, patología oral y cirugía bucal, 2016-03, Vol.21 (2), p.e201-e205

2016

Volltextzugriff (PDF)

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

Breast (Edinburgh), 2020-12, Vol.54, p.286-292

2020

Volltextzugriff (PDF)

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

BMC cancer, 2015-04, Vol.15 (1), p.327-327, Article 327

2015

Volltextzugriff (PDF)

Primary carcinoid tumour of the pancreas

Clinical & translational oncology, 2006-01, Vol.8 (1), p.54-56

2006

Volltextzugriff (PDF)

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study

The breast journal, 2007-11, Vol.13 (6), p.571-574

2007

Volltextzugriff (PDF)

P-0256 Phase II Study to Evaluate Efficacy and Safety of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer (MCRC) Patients

Annals of oncology, 2012-06, Vol.23, p.iv103-iv104

2012

Volltextzugriff (PDF)

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study: Breast Cancer Follow-Up: Cost-Benefit Analysis

The breast journal, 2007-11, Vol.13 (6), p.571-574

2007

Volltextzugriff (PDF)

Extragonadal nongestational choriocarcinoma involving the lung: a report of three cases

Respiration, 1996-01, Vol.63 (4), p.251-253

1996

Volltextzugriff (PDF)

Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer (mCRC) patients

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.501-501

2013

Volltextzugriff (PDF)

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Cancer chemotherapy and pharmacology, 2004, Vol.53 (1), p.75-81

2004

Volltextzugriff (PDF)

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

Clinical & translational oncology, 2015-11, Vol.17 (11), p.862-869

2015

Volltextzugriff (PDF)

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Clinical & translational oncology, 2009-04, Vol.11 (4), p.221-227

2009

Volltextzugriff (PDF)

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Cancer chemotherapy and pharmacology, 2004-01, Vol.53 (1), p.75-81

2004

Volltextzugriff (PDF)

Metastatic follicular thyroid carcinoma to the kidney: a case report

Clinical nuclear medicine, 1999-01, Vol.24 (1), p.48-50

1999

Volltextzugriff (PDF)

Small cell lung cancer in the elderly: factors influencing treatment decision and effect on survival

Revista de oncología (Barcelona, Spain), 2000-11, Vol.2 (6), p.294-300

2000

Volltextzugriff (PDF)

High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

Revista de oncología (Barcelona, Spain), 2003-04, Vol.5 (3), p.148-155

2003

Volltextzugriff (PDF)

Intraoral onlay block bone grafts versus cortical tenting technique on alveolar ridge augmentations: a systematic review

Medicina oral, patología oral y cirugía bucal, 2022-03, Vol.27 (2), p.e181-e190

2022

Volltextzugriff (PDF)

The outcome of intraoral onlay block bone grafts on alveolar ridge augmentations: a systematic review

Medicina oral, patología oral y cirugía bucal, 2015-03, Vol.20 (2), p.e251-e258

2015

Volltextzugriff (PDF)

Is periapical surgery follow-up with only two-dimensional radiographs reliable? A retrospective cohort type sensitivity study

Medicina oral, patología oral y cirugía bucal, 2021-11, Vol.26 (6), p.e711-e718

2021

Volltextzugriff (PDF)

Comparison of the diagnostic efficacy of 2D radiography and cone beam computed tomography in persistent apical periodontal disease: A PRISMA-DTA systematic review and meta-analysis

Oral surgery, oral medicine, oral pathology and oral radiology, 2021-10, Vol.132 (4), p.e153-e168

2021

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(80)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(43)
Humans
(40)
Female
(27)
Middle Aged
(23)
Male
(19)
Adult
(18)
Dentistry, Oral Surgery & Medicine
(16)
Aged
(15)
Dentistry
(15)
Oncology
(11)
Dental Implants
(9)
Treatment Outcome
(9)
Breast Cancer
(8)
Young Adult
(8)
Alveolar Ridge Augmentation - Methods
(7)
Dental Implantation, Endosseous - Methods
(7)
Follow-Up Studies
(7)
Quality Of Life
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

Non surgical predicting factors for patient satisfaction after third molar surgery

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

Primary carcinoid tumour of the pancreas

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study

P-0256 Phase II Study to Evaluate Efficacy and Safety of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer (MCRC) Patients

Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study: Breast Cancer Follow-Up: Cost-Benefit Analysis

Extragonadal nongestational choriocarcinoma involving the lung: a report of three cases

Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer (mCRC) patients

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study)

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

Metastatic follicular thyroid carcinoma to the kidney: a case report

Small cell lung cancer in the elderly: factors influencing treatment decision and effect on survival

High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

Intraoral onlay block bone grafts versus cortical tenting technique on alveolar ridge augmentations: a systematic review

The outcome of intraoral onlay block bone grafts on alveolar ridge augmentations: a systematic review

Is periapical surgery follow-up with only two-dimensional radiographs reliable? A retrospective cohort type sensitivity study

Comparison of the diagnostic efficacy of 2D radiography and cone beam computed tomography in persistent apical periodontal disease: A PRISMA-DTA systematic review and meta-analysis

Suchergebnisse filtern